1. Home
  2. GOSS vs BFLY Comparison

GOSS vs BFLY Comparison

Compare GOSS & BFLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • BFLY
  • Stock Information
  • Founded
  • GOSS 2015
  • BFLY 2011
  • Country
  • GOSS United States
  • BFLY United States
  • Employees
  • GOSS N/A
  • BFLY N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • BFLY Medical Electronics
  • Sector
  • GOSS Health Care
  • BFLY Health Care
  • Exchange
  • GOSS Nasdaq
  • BFLY Nasdaq
  • Market Cap
  • GOSS 501.2M
  • BFLY 560.8M
  • IPO Year
  • GOSS 2019
  • BFLY N/A
  • Fundamental
  • Price
  • GOSS $3.17
  • BFLY $2.42
  • Analyst Decision
  • GOSS Strong Buy
  • BFLY Strong Buy
  • Analyst Count
  • GOSS 6
  • BFLY 3
  • Target Price
  • GOSS $8.60
  • BFLY $3.50
  • AVG Volume (30 Days)
  • GOSS 3.1M
  • BFLY 6.9M
  • Earning Date
  • GOSS 11-05-2025
  • BFLY 10-31-2025
  • Dividend Yield
  • GOSS N/A
  • BFLY N/A
  • EPS Growth
  • GOSS N/A
  • BFLY N/A
  • EPS
  • GOSS N/A
  • BFLY N/A
  • Revenue
  • GOSS $44,051,000.00
  • BFLY $88,447,000.00
  • Revenue This Year
  • GOSS N/A
  • BFLY $13.83
  • Revenue Next Year
  • GOSS $16.11
  • BFLY $18.46
  • P/E Ratio
  • GOSS N/A
  • BFLY N/A
  • Revenue Growth
  • GOSS N/A
  • BFLY 16.04
  • 52 Week Low
  • GOSS $0.66
  • BFLY $1.32
  • 52 Week High
  • GOSS $3.60
  • BFLY $4.98
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 68.68
  • BFLY 54.87
  • Support Level
  • GOSS $2.42
  • BFLY $1.90
  • Resistance Level
  • GOSS $2.71
  • BFLY $2.51
  • Average True Range (ATR)
  • GOSS 0.19
  • BFLY 0.28
  • MACD
  • GOSS 0.09
  • BFLY -0.03
  • Stochastic Oscillator
  • GOSS 96.48
  • BFLY 44.58

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About BFLY Butterfly Network Inc.

Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. The company enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.

Share on Social Networks: